Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Harvard Business School
Dow
Baxter
McKesson

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Hydronidone

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Hydronidone?

Hydronidone is an investigational drug.

There have been 5 clinical trials for Hydronidone. The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2015.

The most common disease conditions in clinical trials are Hepatitis B, Hepatitis, and Liver Cirrhosis. The leading clinical trial sponsors are Beijing Continent Pharmaceutical Co, Ltd., Shanghai Genomics, Inc., and [disabled in preview].

There are seventeen US patents protecting this investigational drug and one hundred and thirty international patents.

Recent Clinical Trials for Hydronidone
TitleSponsorPhase
Study on PK of Hydronidone in Patients and Special PopulationBeijing Continent Pharmaceutical Co, Ltd.Phase 1
Study on Pharmacokinetics of HydronidoneBeijing Continent Pharmaceutical Co, Ltd.Phase 1
Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese SubjectsBeijing Continent Pharmaceutical Co, Ltd.Phase 1

See all Hydronidone clinical trials

Clinical Trial Summary for Hydronidone

Top disease conditions for Hydronidone
Top clinical trial sponsors for Hydronidone

See all Hydronidone clinical trials

US Patents for Hydronidone

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Hydronidone   Start Trial Method of modulating stress-activated protein kinase system INTERMUNE, INC. (Brisbane, CA)   Start Trial
Hydronidone   Start Trial Aerosol pirfenidone and pyridone analog compounds and uses thereof AVALYN PHARMA INC. (Seattle, CA)   Start Trial
Hydronidone   Start Trial Aerosol pirfenidone and pyridone analog compounds and uses thereof AVALYN PHARMA INC. (Seattle, WA)   Start Trial
Hydronidone   Start Trial Aerosol pirfenidone and pyridone analog compounds and uses thereof Avalyn Pharma Inc. (Seattle, WA)   Start Trial
Hydronidone   Start Trial Small molecule therapies for pulmonary hypertension Creighton University (Omaha, NE)   Start Trial
Hydronidone   Start Trial Method of modulating stress-activated protein kinase system Intermune, Inc. (Brisbane, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Hydronidone

Drugname Country Document Number Estimated Expiration Related US Patent
Hydronidone Australia 2006244072 2025-05-10   Start Trial
Hydronidone Brazil PI0608907 2025-05-10   Start Trial
Hydronidone Canada 2608116 2025-05-10   Start Trial
Hydronidone China 101237869 2025-05-10   Start Trial
Hydronidone China 103012254 2025-05-10   Start Trial
Hydronidone Cyprus 1115795 2025-05-10   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Moodys
Johnson and Johnson
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.